MDS Posts
What do the recent long-term COMMANDS data show?
Dr. Guillermo Garcia-Manero and the panel discuss long-term data from the COMMANDS trial in lower-risk MDS.
SOHO president looks back on 2024
For SOHO, 2024 was a year of firsts and continued growth of the society worldwide.
Dr. Santini talks MDS ASH highlights from San Diego
In this video filmed at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, Valeria Santini, MD, an associate professor of hematology at the University of Florence Medical […]
Smoking associated with MDS mutations, progression
Results from a prospective study presented at the American Society of Hematology Annual Meeting & Exposition showed that tobacco smoking was associated with disease progression and with distinct genetic mutations […]
Key factors drive MDS progression
Patients with myelodysplastic syndromes (MDS) face varying progression risks based on clinical factors such as low hemoglobin levels and platelet counts, according to an abstract presented at the 66th American […]
